CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

state.tx.us

Questcare Management Svc Inc

Questcare Management Svc Inc is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Xercise Inc

Xercise Inc is a Chester, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alliance Clinical Associates

Alliance Clinical Associates is a mental health clinic that offers a wide range of services to address emotional and mental health problems. They provide services to children, teens, adults, and the aging population from a faith-sensitive perspective.

Electro-Optical Sciences

Electro-Optical Sciences is a Irvington, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.